We propose that, in SSA, hyperinsulinaemia due to a combination of both increased insulin secretion and reduced hepatic insulin clearance may be the primary aetiological factor, which promotes obesity [17] and insulin resistance, exacerbating the hyperinsulinaemia and eventually leading to beta cell failure and type 2 diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.